In your opinion, when is it time to switch from Fin to Dut? 9/19/2022
User discusses switching from Finasteride to Dutasteride for hair loss treatment. Others share experiences and suggest trying Avodart or RU58841.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Ashton Kutcher talking about Avodart/Dutasteride on national television
How actor Ashton Kutcher used Dutasteride (Avodart) to treat his hair loss at age 25, but stopped taking it due to potential side effects when he wanted to have kids; and the discussion of various treatments for hair loss such as finasteride, minoxidil, and RU58841.
community Dutasteride 1.5 years and Oral Minoxidil 1 year progress!
A user switched from finasteride to dutasteride and added oral minoxidil for hair loss but saw limited improvement. They are considering increasing doses, trying RU58841, and possibly a hair transplant, while others suggest checking for vitamin deficiencies.
community Topical Finasteride reduced my DHT more than Oral Dutasteride
Treatments for hair loss, including the experiences of topical finasteride and oral dutasteride. It also discusses Pyrilutamide, 0.025% topical concentration, Minoxidil, RU58841, and 1% finasteride gel dosage.
community Is the a way to get dutasteride in france without prescription
Hair loss treatments discussed include Minoxidil, Finasteride, and RU58841. A user suggests using EUdoctor app to get a prescription for Dutasteride and shares the cost breakdown.
community Anyone start dut after many years of fin? Did you see any regrowth?
The conversation discusses switching from finasteride to dutasteride after many years to improve hair regrowth, with mixed experiences reported. One user has also used minoxidil and is hesitant to try RU58841 due to concerns about side effects and safety.
community Burning sensation and acne along temples accompanied by aggressive recession. On 0.5mg dut, 1.25mg fin EOD, and oral min 5mg daily.
The user experienced temple recession, shedding, and acne while on 0.5mg dutasteride, 1.25mg finasteride every other day, and 5mg oral minoxidil daily. They are considering switching treatments due to worsening symptoms and are contemplating using a topical anti-androgen like RU58841.
Related Research
6 / 6 results
research Antiandrogens and Androgen Inhibitors
This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.
research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
This thesis investigates the underlying mechanisms and treatment options for androgenetic alopecia, highlighting the molecular roles of androgens and genetic predispositions, and evaluates current and emerging therapies, such as PROTACs and Janus Kinase inhibitors, to enhance patient management.
research Drug discovery for alopecia: gone today, hair tomorrow
This review discusses current knowledge on the biological mechanisms of different types of alopecia but reports no new clinical findings; the authors highlight future research directions, especially regarding epidermal stem cells and immune pathways.
research Post-finasteride syndrome: our current knowledge
This review examines the contentious issue of post-finasteride syndrome linked to 5-alpha reductase inhibitors and reports mixed findings on its sexual, physical, and psychological effects; the authors call for more rigorous studies.
research Steroid Hormones
This article discusses the various roles of steroids in vertebrate organ systems and notes several glucocorticoids that were among the Top 200 Drugs by sales in the 2010s, but it reports no new clinical findings.
research Androgens and Parkinson’s disease: the role in humans and in experiment
This review discusses sex differences in Parkinson's disease and highlights that while men are more frequently affected, androgen-modulating treatments have not yet proven effective for PD, though 5α-reductase inhibitors show potential for further study.